miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma

Shi,Jipeng; Yang,Liuzhong; Wang,Tuanjie; Zhang,Jian; Guo,Xixia; Huo,Xiaoqing; Niu,Hongrui

doi:10.3892/mmr.2013.1639

miR-218 is downregulated and directly targets SH3GL1 in childhood medulloblastoma

Authors:
- Jipeng Shi
- Liuzhong Yang
- Tuanjie Wang
- Jian Zhang
- Xixia Guo
- Xiaoqing Huo
- Hongrui Niu
View Affiliations

Affiliations: Department of Neonatology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China, Department of Medical Oncology, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China, Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China
Published online on: August 16, 2013 https://doi.org/10.3892/mmr.2013.1639
Pages: 1111-1117

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

An increasing number of studies have suggested that microRNAs (miRNAs) are aberrantly expressed in numerous types of tumors and that a deregulation in miRNA expression may lead to carcinogenesis. Although miR‑218 has been demonstrated to be downregulated in several types of cancer, including medulloblastoma (MB), its involvement in MB is unclear. In the present study, the expression of miR‑218 and SH3GL1 were assessed in four MB cell lines and normal cerebellum by qPCR. The ectopic expression of miR‑218 induced by lentiviral transfection in MB cells on proliferation was evaluated by MTT assay, and cell migration and invasion were determined by transwell assays. Analysis of the target protein expression and related protein expression was determined by western blot analysis. The targeting of SH3GL1 by miR‑218 was identified using a luciferase reporter assay. The results demonstrated that miR‑218 was significantly downregulated in MB cell lines. MiR‑218 significantly inhibited SH3GL1 mRNA and protein expression and reduced the luciferase activity of a SH3GL1 3' untranslated region‑based reporter. Furthermore, overexpression of miR‑218 induced by transfection with lentivirus significantly suppressed MB cell growth, migration and invasion in vitro. Small interfering RNA‑mediated SH3GL1 downregulation partially phenocopied the effect of miR‑218 overexpression in the MB cell lines. The results indicated that miR‑218 was significantly downregulated in MB cancer cell lines. Furthermore, miR‑218 functioned as a tumor suppressor by regulating SH3GL1 expression in MB cancer cells.

View Figures

View References

1	Gilbertson RJ and Ellison DW: The origins of medulloblastoma subtypes. Annu Rev Pathol. 3:341–365. 2008. View Article : Google Scholar : PubMed/NCBI
2	Ellison DW, Kocak M, Dalton J, et al: Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables. J Clin Oncol. 29:1400–1407. 2011. View Article : Google Scholar
3	No authors listed. 43rd Congress of the International Society of Paediatric Oncology (SIOP) 2011. In: Auckland, New Zealand. 28th–30th October, 2011; SIOP Abstracts Pediatr Blood Cancer. 57. pp. 705–897. 2011, PubMed/NCBI
4	Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 116:281–297. 2004. View Article : Google Scholar : PubMed/NCBI
5	Wu L, Fan J and Belasco JG: MicroRNAs direct rapid deadenylation of mRNA. Proc Natl Acad Sci USA. 103:4034–4039. 2006. View Article : Google Scholar : PubMed/NCBI
6	Krol J, Loedige I and Filipowicz W: The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
7	Filipowicz W, Bhattacharyya SN and Sonenberg N: Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 9:102–114. 2008. View Article : Google Scholar : PubMed/NCBI
8	Shenouda SK and Alahari SK: MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metastasis Rev. 28:369–378. 2009. View Article : Google Scholar : PubMed/NCBI
9	Garzon R, Calin GA and Croce CM: MicroRNAs in cancer. Annu Rev Med. 60:167–179. 2009. View Article : Google Scholar
10	Uziel T, Karginov FV, Xie S, et al: The miR-17~92 cluster collaborates with the Sonic Hedgehog pathway in medulloblastoma. Proc Natl Acad Sci USA. 106:2812–2817. 2009. View Article : Google Scholar : PubMed/NCBI
11	Ferretti E, De Smaele E, Po A, et al: MicroRNA profiling in human medulloblastoma. Int J Cancer. 124:568–577. 2009. View Article : Google Scholar : PubMed/NCBI
12	Genovesi LA, Anderson D, Carter KW, et al: Identification of suitable endogenous control genes for microRNA expression profiling of childhood medulloblastoma and human neural stem cells. BMC Res Notes. 5:5072012. View Article : Google Scholar
13	Northcott PA, Fernandez-L A, Hagan JP, et al: The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 69:3249–3255. 2009. View Article : Google Scholar
14	Grunder E, D’Ambrosio R, Fiaschetti G, et al: MicroRNA-21 suppression impedes medulloblastoma cell migration. Eur J Cancer. 47:2479–2490. 2011. View Article : Google Scholar : PubMed/NCBI
15	Venkataraman S, Birks DK, Balakrishnan I, et al: MicroRNA 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J Biol Chem. 288:1918–1928. 2013. View Article : Google Scholar
16	Shapiro RH and Chang AL: Urgent radiotherapy is effective in the treatment of metastatic medulloblastoma causing symptomatic brainstem edema. Pediatr Blood Cancer. 57:1077–1080. 2011. View Article : Google Scholar
17	Gajjar A and Pizer B: Role of high-dose chemotherapy for recurrent medulloblastoma and other CNS primitive neuroectodermal tumors. Pediatr Blood Cancer. 54:649–651. 2010. View Article : Google Scholar : PubMed/NCBI
18	Taniguchi E, Cho MJ, Arenkiel BR, et al: Bortezomib reverses a post-translational mechanism of tumorigenesis for patched1 haploinsufficiency in medulloblastoma. Pediatr Blood Cancer. 53:136–144. 2009. View Article : Google Scholar : PubMed/NCBI
19	Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006. View Article : Google Scholar : PubMed/NCBI
20	Song L, Huang Q, Chen K, et al: miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun. 402:135–140. 2010.PubMed/NCBI
21	Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006. View Article : Google Scholar : PubMed/NCBI
22	Ringstad N, Nemoto Y and De Camilli P: The SH3p4/Sh3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a Grb2-like Src homology 3 domain. Proc Natl Acad Sci USA. 94:8569–8574. 1997. View Article : Google Scholar
23	So CW, So CK, Cheung N, et al: The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: implications for leukaemogenesis. Leukemia. 14:594–601. 2000. View Article : Google Scholar : PubMed/NCBI
24	Tanaka K, Babic I, Nathanson D, et al: Oncogenic EGFR signaling activates an mTORC2-NF-kappaB pathway that promotes chemotherapy resistance. Cancer Discov. 1:524–538. 2011. View Article : Google Scholar : PubMed/NCBI
25	Lua BL and Low BC: Activation of EGF receptor endocytosis and ERK1/2 signaling by BPGAP1 requires direct interaction with EEN/endophilin II and a functional RhoGAP domain. J Cell Sci. 118:2707–2721. 2005. View Article : Google Scholar
26	Ma LH, Liu H, Xiong H, et al: Aberrant transcriptional regulation of the MLL fusion partner EEN by AML1-ETO and its implication in leukemogenesis. Blood. 109:769–777. 2007. View Article : Google Scholar : PubMed/NCBI
27	Uesugi A, Kozaki K, Tsuruta T, et al: The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res. 71:5765–5778. 2011. View Article : Google Scholar : PubMed/NCBI
28	Fish JE, Wythe JD, Xiao T, et al: A Slit/miR-218/Robo regulatory loop is required during heart tube formation in zebrafish. Development. 138:1409–1419. 2011. View Article : Google Scholar : PubMed/NCBI
29	Hassan MQ, Maeda Y, Taipaleenmaki H, et al: miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI